Cargando…
Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility
BACKGROUND: We aim to deliver large appliances into the left ventricle through the right ventricle and across the interventricular septum. This transthoracic access route exploits immediate recoil of the septum, and lower transmyocardial pressure gradient across the right versus left ventricular fre...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174899/ https://www.ncbi.nlm.nih.gov/pubmed/23331459 http://dx.doi.org/10.1186/1532-429X-15-10 |
_version_ | 1782336423045627904 |
---|---|
author | Halabi, Majdi Ratnayaka, Kanishka Faranesh, Anthony Z Hansen, Michael S Barbash, Israel M Eckhaus, Michael A Wilson, Joel R Chen, Marcus Y Slack, Michael C Kocaturk, Ozgur Schenke, William H Wright, Victor J Lederman, Robert J |
author_facet | Halabi, Majdi Ratnayaka, Kanishka Faranesh, Anthony Z Hansen, Michael S Barbash, Israel M Eckhaus, Michael A Wilson, Joel R Chen, Marcus Y Slack, Michael C Kocaturk, Ozgur Schenke, William H Wright, Victor J Lederman, Robert J |
author_sort | Halabi, Majdi |
collection | PubMed |
description | BACKGROUND: We aim to deliver large appliances into the left ventricle through the right ventricle and across the interventricular septum. This transthoracic access route exploits immediate recoil of the septum, and lower transmyocardial pressure gradient across the right versus left ventricular free wall. The route may enhance safety and allow subxiphoid rather than intercostal traversal. METHODS: The entire procedure was performed under real-time CMR guidance. An “active” CMR needle crossed the chest, right ventricular free wall, and then the interventricular septum to deliver a guidewire then used to deliver an 18Fr introducer. Afterwards, the right ventricular free wall was closed with a nitinol occluder. Immediate closure and late healing of the unrepaired septum and free wall were assessed by oximetry, angiography, CMR, and necropsy up to four weeks afterwards. RESULTS: The procedure was successful in 9 of 11 pigs. One failed because of refractory ventricular fibrillation upon needle entry, and the other because of inadequate guidewire support. In all ten attempts, the right ventricular free wall was closed without hemopericardium. There was neither immediate nor late shunt on oximetry, X-ray angiography, or CMR. The interventricular septal tract fibrosed completely. Transventricular trajectories planned on human CT scans suggest comparable intracavitary working space and less acute entry angles than a conventional atrial transseptal approach. CONCLUSION: Large closed-chest access ports can be introduced across the right ventricular free wall and interventricular septum into the left ventricle. The septum recoils immediately and heals completely without repair. A nitinol occluder immediately seals the right ventricular wall. The entry angle is more favorable to introduce, for example, prosthetic mitral valves than a conventional atrial transseptal approach. |
format | Online Article Text |
id | pubmed-4174899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41748992014-09-26 Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility Halabi, Majdi Ratnayaka, Kanishka Faranesh, Anthony Z Hansen, Michael S Barbash, Israel M Eckhaus, Michael A Wilson, Joel R Chen, Marcus Y Slack, Michael C Kocaturk, Ozgur Schenke, William H Wright, Victor J Lederman, Robert J J Cardiovasc Magn Reson Research BACKGROUND: We aim to deliver large appliances into the left ventricle through the right ventricle and across the interventricular septum. This transthoracic access route exploits immediate recoil of the septum, and lower transmyocardial pressure gradient across the right versus left ventricular free wall. The route may enhance safety and allow subxiphoid rather than intercostal traversal. METHODS: The entire procedure was performed under real-time CMR guidance. An “active” CMR needle crossed the chest, right ventricular free wall, and then the interventricular septum to deliver a guidewire then used to deliver an 18Fr introducer. Afterwards, the right ventricular free wall was closed with a nitinol occluder. Immediate closure and late healing of the unrepaired septum and free wall were assessed by oximetry, angiography, CMR, and necropsy up to four weeks afterwards. RESULTS: The procedure was successful in 9 of 11 pigs. One failed because of refractory ventricular fibrillation upon needle entry, and the other because of inadequate guidewire support. In all ten attempts, the right ventricular free wall was closed without hemopericardium. There was neither immediate nor late shunt on oximetry, X-ray angiography, or CMR. The interventricular septal tract fibrosed completely. Transventricular trajectories planned on human CT scans suggest comparable intracavitary working space and less acute entry angles than a conventional atrial transseptal approach. CONCLUSION: Large closed-chest access ports can be introduced across the right ventricular free wall and interventricular septum into the left ventricle. The septum recoils immediately and heals completely without repair. A nitinol occluder immediately seals the right ventricular wall. The entry angle is more favorable to introduce, for example, prosthetic mitral valves than a conventional atrial transseptal approach. BioMed Central 2013-01-18 /pmc/articles/PMC4174899/ /pubmed/23331459 http://dx.doi.org/10.1186/1532-429X-15-10 Text en Copyright © 2013 Halabi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Halabi, Majdi Ratnayaka, Kanishka Faranesh, Anthony Z Hansen, Michael S Barbash, Israel M Eckhaus, Michael A Wilson, Joel R Chen, Marcus Y Slack, Michael C Kocaturk, Ozgur Schenke, William H Wright, Victor J Lederman, Robert J Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility |
title | Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility |
title_full | Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility |
title_fullStr | Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility |
title_full_unstemmed | Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility |
title_short | Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility |
title_sort | transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174899/ https://www.ncbi.nlm.nih.gov/pubmed/23331459 http://dx.doi.org/10.1186/1532-429X-15-10 |
work_keys_str_mv | AT halabimajdi transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT ratnayakakanishka transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT faraneshanthonyz transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT hansenmichaels transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT barbashisraelm transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT eckhausmichaela transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT wilsonjoelr transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT chenmarcusy transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT slackmichaelc transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT kocaturkozgur transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT schenkewilliamh transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT wrightvictorj transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility AT ledermanrobertj transthoracicdeliveryoflargedevicesintotheleftventriclethroughtherightventricleandinterventricularseptumpreclinicalfeasibility |